Skip to main content

Table 2 Clinical manifestations of patients with Behçhet's disease in relation to anti-Sip1 C-ter autoantibodies

From: Identification and characterization of the carboxy-terminal region of Sip-1, a novel autoantigen in Behçet's disease

Clinical manifestation of the 56 patients with Behçet's disease Number of total samples (%) Anti-Sip1 C-ter antibody response, number of positive samples (%)
   IgG IgM IgA
Skin lesions 36 (64) 7 (19) 14 (39) 7 (19)
Ocular inflammation 38 (68) 8 (21) 16 (42) 5 (13)
Genital aphtosis 27 (48) 5 (18) 8 (29) 5 (18)
Arthritis 10 (18) 1 (10) 6 (60) 2 (20)
Vascular manifestations 10 (18) 4 (40) 6 (60) 4 (40)
Neurological manifestations 6 (11) 0 1 (1.6) 0
  1. Sip1 C-ter, carboxy-terminal subunit of Sip1.